PVCT - Provectus Biopharmaceuticals, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 526.36M
Enterprise Value 344.06M
Trailing P/E N/A
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)N/A
Price/Book (mrq)N/A
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 6-7.21

Trading Information

Stock Price History

Beta (3Y Monthly) 1.55
52-Week Change 3-5.71%
S&P500 52-Week Change 32.63%
52 Week High 30.0780
52 Week Low 30.0110
50-Day Moving Average 30.0664
200-Day Moving Average 30.0584

Share Statistics

Avg Vol (3 month) 3280.27k
Avg Vol (10 day) 3161.79k
Shares Outstanding 5387.59M
Float 370.18M
% Held by Insiders 14.55%
% Held by Institutions 10.04%
Shares Short (Sep 30, 2016) 41.82M
Short Ratio (Sep 30, 2016) 40.47
Short % of Float (Sep 30, 2016) 40.79%
Short % of Shares Outstanding (Sep 30, 2016) 40.75%
Shares Short (prior month Aug 31, 2016) 42.86M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2300/1
Last Split Date 3Apr 11, 2002

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Jun 30, 2019


Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-136.71%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
Net Income Avi to Common (ttm)-7.34M
Diluted EPS (ttm)-0.0190
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)1.32M
Total Cash Per Share (mrq)0
Total Debt (mrq)19.03M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.39
Book Value Per Share (mrq)-0.05

Cash Flow Statement

Operating Cash Flow (ttm)-5.29M
Levered Free Cash Flow (ttm)-3.78M